Press enter to search
Close search
Open Menu


News and information on retail pharmacy, including generic drugs, branded drugs, specialty pharmacy medications, pharmacy technology and legislative updates.

NACDS’ online maps show which states empower pharmacies to meet COVID-19 demand

NACDS’ online maps show further action is needed to remove barriers to pharmacy patient care immediately.

A pharmacist with a patient.

NCPA recognizes front-line pharmacists with new video

NCPA CEO Doug Hoey applauds community pharmacists for their efforts in the fight against COVID-19.

CVS exterior.

CVS Health is providing Massachusetts residents with on-the-spot COVID-19 testing and results at no cost, using the new Abbott ID NOW COVID-19 test.

Sandoz will continue to operate its oral solids and dermatology business as part of the Sandoz U.S. business.

CVS Health's rapid COVID-19 drive-through testing sites in Georgia, and Rhode Island will provide on the spot test results, while its pop-up pharmacy in New Orleans will provide maintenance medication and counseling for certain COVID-19 patients.

Innovation co-president Marvin Richardson takes over as CEO on April 25, succeeding Mary Reno, and co-president Tom Boyer will become chief strategy officer.

CVS exterior.

CVS Pharmacy field leaders and managers will select local organizations to receive donations.

A pharmacist handing a prescription to a patient.

A new Indiana law allows a pharmacist to substitute a therapeutic alternative for epinephrine products.

Aurobindo's generic Zanaflex will be available in three dosage strengths.

A pharmacist holding a prescription box.

Mycophenolic acid delayed-release tablets had a market value of roughly $156 million, according to IQVIA data from February.

According to a survey commissioned by NACDS, 86% of voters say pharmacists should be allowed to provide tests for COVID-19, and the same number say pharmacists should be able to administer a vaccine once developed.

CVS Pharmacy announced new employee benefits and safety measures to keep employees and customers safe during the COVID-19 pandemic.

Vyepti is the first and only intravenous treatment for migraine prevention.

Show More